Market Closed -
Other stock markets
|
After market 04:00:10 am | |||
152.7 USD | +0.37% |
|
152 | -0.44% |
26/06 | Monetary policy is getting even more confusing | ![]() |
26/06 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.32% | 1.44TCr | |
+20.63% | 13TCr | |
+24.16% | 2.77TCr | |
-20.17% | 2.03TCr | |
-16.06% | 1.68TCr | |
-18.07% | 1.56TCr | |
-47.70% | 1.46TCr | |
+11.92% | 1.48TCr | |
+149.98% | 1.25TCr | |
-10.27% | 984.15Cr |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 07